Adaptive biotech Corp Live Stock Price Today, Share Analysis and Chart

Name: Adaptive Biotechnologies Corp: Is Infosys Ltd. worth buying?
Item: Adaptive Biotechnologies Corp
Rating: 1.242736125
Author: Trendlyne DVM scores

Weak Stock

about

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, ...

13.18 0.05 (0.38%)

36.51% Fall from 52W High

1.6M

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Low Financial Strength

27.8 / 100

Expensive Valuation

10.8 / 100

Technically Bearish

33.0 / 100

Weak Stock These stocks have poor scores across the board. Investors should be very cautious with these stocks View Similar Embed DVM

1Yr Price target upside is 53%

7 analysts

Adaptive biotech Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Adaptive biotech Corp Live Stock Price Today, Share Analysis and Chart

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, ...

36.51% Fall from 52W High

SWOT Analysis

Adaptive biotech Corp Live Price Chart